Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 128486-54-4
2. Gr-87442
3. G694g740zp
4. 6-fluoro-5-methyl-2-[(5-methyl-1h-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one
5. Lurosetron [inn:ban]
6. Unii-g694g740zp
7. Lurosetron [inn]
8. Schembl788289
9. Chembl2105137
10. Dtxsid30155911
11. Q27882160
12. 1h-pyrido(4,3-b)indol-1-one, 6-fluoro-2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1h-imidazol-4-yl)methyl)-
13. 6-fluoro-2,3,4,5-tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1h-pyrido(4,3-b)indol-1-one
14. 6-fluoro-2,3,4,5-tetrahydro-5-methyl-2-[(5-methyl -1h-imidazol-4-yl)methyl]-1h-pyrido[4,3-b]indol-1-one
15. 6-fluoro-2,3,4,5-tetrahydro-5-methyl-2-[(5-methyl-1h-imidazol -4-yl)methyl]-1h-pyrido[4,3-b]indol-1-one
16. 6-fluoro-2,3,4,5-tetrahydro-5-methyl-2-[(5-methyl-1h-imidazol-4-yl) Methyl]-1h-pyrido[4,3-b]indol-1-one
17. 6-fluoro-2,3,4,5-tetrahydro-5-methyl-2-[(5-methyl-1h-imidazol-4-yl)methyl]-1h-pyrido[4,3-b]indol-1-one
18. 6-fluoro2,3,4,5-tetrahydro-5-methyl-2-[(5-methyl-1h-imidazol-4-yl)methyl]-1h-pyrido[4,3-b]indol-1-one
| Molecular Weight | 312.34 g/mol |
|---|---|
| Molecular Formula | C17H17FN4O |
| XLogP3 | 1.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 312.13863934 g/mol |
| Monoisotopic Mass | 312.13863934 g/mol |
| Topological Polar Surface Area | 53.9 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 476 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
63
PharmaCompass offers a list of Lurosetron API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lurosetron manufacturer or Lurosetron supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lurosetron manufacturer or Lurosetron supplier.
PharmaCompass also assists you with knowing the Lurosetron API Price utilized in the formulation of products. Lurosetron API Price is not always fixed or binding as the Lurosetron Price is obtained through a variety of data sources. The Lurosetron Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lurosetron manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lurosetron, including repackagers and relabelers. The FDA regulates Lurosetron manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lurosetron API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lurosetron supplier is an individual or a company that provides Lurosetron active pharmaceutical ingredient (API) or Lurosetron finished formulations upon request. The Lurosetron suppliers may include Lurosetron API manufacturers, exporters, distributors and traders.
Lurosetron Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lurosetron GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lurosetron GMP manufacturer or Lurosetron GMP API supplier for your needs.
A Lurosetron CoA (Certificate of Analysis) is a formal document that attests to Lurosetron's compliance with Lurosetron specifications and serves as a tool for batch-level quality control.
Lurosetron CoA mostly includes findings from lab analyses of a specific batch. For each Lurosetron CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lurosetron may be tested according to a variety of international standards, such as European Pharmacopoeia (Lurosetron EP), Lurosetron JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lurosetron USP).
